All News
Non-Surgical Option Approved for Recurrent Low-Grade Bladder Cancer
(MedPage Today) -- The FDA approved mitomycin intravesical solution (Zusduri) as a nonsurgical option for recurrent low-grade, intermediate-risk non-muscle invasive bladder cancer (NMIBC).
Read MoreKFF Health News' 'What the Health?': RFK Jr. Upends Vaccine Policy, After Promising He Wouldn’t
Health and Human Services Secretary Robert F. Kennedy Jr.
Read MoreLone Passenger Survives the Deadly Air India Crash
(MedPage Today) -- The lone passenger to survive the Air India crash that killed at least 240 people Thursday found himself near debris after being thrown out of the plane and walked to a nearby ambu
Read MoreOpinion: I study conflicts of interest. Here’s why RFK Jr’s approach to the vaccine advisory committee could backfire
Ridding the government, including CDC’s vaccine advisory committee, of industry interests should not play out this way, writes an expert on conflicts of interest.
Read MoreDoctors Outraged Over ACIP Firings; MD Runs for Senate; RN Says No to 'Propaganda'
(MedPage Today) -- The following contains links to social media websites including Bluesky, X, TikTok, Instagram, Facebook, and LinkedIn. In response to HHS Secretary Robert F. Kennedy Jr.
Read MoreShining a Light on the World of Microproteins
From viruses to humans, life makes microproteins that have evaded discovery until now.
Read MoreSurgical Blood Conservation Technique Falls Short in Trial
(MedPage Today) -- A technique to save on blood transfusions during heart surgery, by reinfusion of the patient's own blood, did not pan out when tested in a larger multinational trial.
Read MoreInvestigational Long-Acting Drug Safe in Phenotypic MASH
(MedPage Today) -- Investigational efimosfermin alfa was safe and well tolerated among patients with phenotypic metabolic dysfunction-associated steatohepatitis (MASH), a randomized phase IIa trial s
Read MoreMore Data Back CAR T-Cell Therapy for Lupus, With Promise of Wider Availability
(MedPage Today) -- BARCELONA -- Chimeric antigen receptor (CAR) T-cell therapy for rheumatologic disease is now expanding out of academe into the commercial space, with encouraging new data reporte
Read MorePatients With Pretreated DME May Need More Frequent Aflibercept Injections
(MedPage Today) -- Patients with prior treatment for diabetic macular edema (DME) may require more frequent dosing of aflibercept (Eylea), according to a subgroup analysis of the PHOTON trial present
Read More